Cargando…
Proposal for defining the relevance of drug accumulation derived from single dose study data for modified release dosage forms
Recently, the European Medicines Agency (EMA) published the new draft guideline on the pharmacokinetic and clinical evaluation of modified release (MR) formulations. The draft guideline contains the new requirement of performing multiple dose (MD) bioequivalence studies, in the case when the MR form...
Autores principales: | Scheerans, Christian, Heinig, Roland, Mueck, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405076/ https://www.ncbi.nlm.nih.gov/pubmed/25327367 http://dx.doi.org/10.1002/bdd.1923 |
Ejemplares similares
-
Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
por: Scheerans, Christian, et al.
Publicado: (2011) -
Osmotic Drug Delivery System as a Part of Modified Release Dosage Form
por: Keraliya, Rajesh A., et al.
Publicado: (2012) -
Artificial Neural Networks in Evaluation and Optimization of Modified Release Solid Dosage Forms
por: Ibrić, Svetlana, et al.
Publicado: (2012) -
Hot-Melt 3D Extrusion for the Fabrication of Customizable Modified-Release Solid Dosage Forms
por: Lee, Jaemin, et al.
Publicado: (2020) -
Defining dosage
por: Pellis, Tommaso
Publicado: (2015)